Position of the Transparency Council – Acarizax – standardized allergen extract from house dust mites (Dermatophagoides pteronyssinus, Dermatophagoides farina)
At its meeting on 30 June 2025, the Transparency Council adopted position No. 79/2025 on the evaluation of the drug Acarizax – standardized allergen extract of house dust mites (Dermatophagoides pteronyssinus, Dermatophagoides farina) for the indication: allergic rhinitis